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Abstract 
Objective: To examine the impact of delirium during their ICU stay on long-term health related 
quality of life (HRQoL) and cognitive function (CF) in ICU survivors. 
Design: Prospective 18 month follow-up study. 
Setting: Four ICU-units of a university hospital. 
Patients: A median of 18 months after ICU discharge, questionnaires were sent to 1292 ICU 
survivors with (n=272) and without (n=1020) delirium during their ICU stay.  
Measurements and Main Results: The short form-36v1 (SF-36), checklist individual strength 
(CIS-)fatigue and cognitive failure questionnaire (CFQ) were used. Covariance analysis was 
performed to adjust for relevant covariates. Of the 915 responders, 171 patients were delirious 
during their ICU stay (median age 65 [IQR 58-85], APACHE-II score 17 [IQR 14-20]), and 745 
patients were not (median age 65 [IQR 57-72], APACHE-II score 13 [IQR 10-16]). After 
adjusting for covariates, no differences were found between delirium and non-delirium survivors 
on the SF-36 and CIS-fatigue. However, survivors who had suffered from delirium reported that 
they made significantly more social blunders and their total CFQ score was significantly higher 
compared to survivors who had not been delirious. Survivors of a hypoactive delirium subtype 
performed significantly better on the domain mental health than mixed and hyperactive delirium 
patients. Duration of delirium was significantly correlated to problems with memory and names.  
Conclusions  
ICU survivors with delirium during their ICU stay had a similar adjusted health related quality of 
life evaluation, but significantly more cognitive problems than those who did not suffer from 
delirium, even after adjusting for relevant covariates. In addition, the duration of delirium is 
related to long-term cognitive problems.  
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Introduction  
Delirium is a disorder that frequently occurs in ICU patients (1-3) and is recognized as acute 
brain dysfunction with changes in consciousness and cognition which fluctuate during the day 
(4). This disorder is associated with serious health problems and long-term cognitive impairment 
(5;6). Generally, without distinguishing between delirium and non-delirium patients, 25 to 78% of 
ICU patients experience cognitive impairments after discharge from the ICU (7) emphasizing the 
need for more attention in the period following critical illness. There is a growing interest in 
Health Related Quality of Life (HRQoL) after ICU discharge (8-13). HRQoL questionnaires are 
usually subdivided into dimensions relating to physical, mental and social functioning. It is 
recognized that the value of measurements of cognitive functioning with a general HRQoL 
questionnaire is limited in this setting and specific surveys measuring patients cognitive 
functioning, such as the validated self-reporting cognitive failure questionnaire (CFQ) (14), have 
been developed. 
Only two studies have examined the impact of delirium on HRQoL in ICU survivors (6;13). 
These studies were rather small, relatively short with a maximum follow-up of 3 and 12 months, 
and no analyses of the delirium subtypes were performed (6;13). A significant difference 
between delirium and non-delirium patients in role-physical function, which mostly reflects 
functioning in daily activities, was reported (13), however no correction for disease severity was 
performed (13). This implies that these findings could be the result of an epiphenomenon. The 
duration of delirium during patients’ ICU stay was associated with their observed impaired 
cognitive performance (6). Little is known about the long-term (>1 year) effects of delirium on 
aspects of the HRQoL in this specific group of patients. In addition, it is unknown if there are 
differences in HRQoL (including cognitive function) for subtypes of delirium (3) and if there is a 
correlation between the duration of delirium and HRQoL. 
Therefore the aim of this study was to compare the health related quality of life, including self-
reported cognitive functioning, in ICU survivors with delirium during their ICU stay with those 
that did not suffer from delirium, after a median of 18 months after ICU discharge. Furthermore, 
we examined the correlations between duration of delirium and HRQoL and if subtypes of 
delirium exerted different effects on HRQoL. 
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Material and Methods 
Subjects  
All consecutive patients admitted to the intensive care unit of the Radboud University Nijmegen 
Medical Centre between February 2008 and February 2009 were screened for delirium three 
times a day with the confusion assessment method (CAM)-ICU (1;15) by well trained ICU 
nurses (16). In February 2010, after a median duration of 18 months after ICU discharge, we 
evaluated the health related quality of life of the surviving patients. The regional Medical Ethical 
Committee approved the study (study number 2010/008) and waived the need for informed 
consent, since the objective of this study was to evaluate regular patient care. 
 
Procedures  
All ICU patients were included in this study except those: admitted for less than 1 day; suffering 
from sustained coma on the ICU; with serious auditory or visual disorders; who were unable to 
understand Dutch; who were severely mentally disabled; suffering from a serious receptive 
aphasia or whose delirium screening was not complete during their ICU stay. Patients were 
diagnosed with delirium when they had at least one positive CAM-ICU screening during their 
complete ICU stay, as previously described (17;18). To secure the quality of the delirium 
diagnosis medical and nursing files of all patients were also screened daily for signs of delirium 
(19). When the files contained signs of delirium without a positive CAM-ICU screening or 
conversely, patients were additionally screened by a delirium expert according to the DSM-IV 
criteria (20) to rule out false negatives and positives. In total 17 patients (1.1%) were additionally 
screened this way by a delirium expert. Patients with delirium were divided in three subtypes 
(3): hyperactive delirium subtype with symptoms of hyper alertness and agitation (RASS +1/+4), 
hypoactive subtype in which the patient is hypo alert, lethargic (RASS 0/-3), and the alternating 
or mixed subtype (RASS +4/-3). This last subtype of delirium is characterised by alternating 
symptoms of hyperactive and hypo active delirium.  
 
Demographic variables as well as data of severity of illness, delirium duration and delirium 
subtype of these patients were collected. 
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At median 18 months after ICU discharge, an HRQoL survey was sent out to the cohort of ICU 
survivors. Four weeks after this a reminder letter was sent to the non-responders. We used 
three different validated instruments to measure the HRQoL. We will refer to these three tests 
as the HRQoL. Although there is no specific HRQoL instrument for ICU-patients, recommended 
instruments for ICU patients are the short form-36 (SF-36) and the EuroQoL-5D (21). We used 
the validated Dutch version of the short form-36 (SF-36) version 1 (22) containing 8 multi-item 
dimensions: physical functioning (PF), role-physical (RP), bodily pain (BP), general health (GH), 
vitality (VT), social functioning (SF), role-emotional (RE) and mental health (MH). Aggregated 
summary scores were calculated for physical and mental functioning expressed in physical 
component score (PCS) and mental component score (MCS), respectively. To calculate the 
PCS and MCS we used the standardized Dutch population scores (23). In line with the SF-36 
Health Survey Manual (24) missing values were imputed, data were recoded and subsequently 
scored (range 0 to 100). A higher score indicates a higher level of functioning. Additionally, the 
shortlist of the Dutch validated checklist individual strength-fatigue (CIS-fatigue), consisting of 8 
questions scoring on a 7 point Likert scale (25), was used. The range of the CIS-fatigue is 8-56, 
a higher score indicating more pronounced fatigue. The third instrument was the validated 
Dutch translation (26) of the cognitive failure questionnaire (CFQ) which is a self-reported 
cognitive functioning questionnaire. This questionnaire consists of 25 questions (14). The self-
reported CFQ measures consists of four dimensions (27) of cognition: memory, distractibility, 
social blunders and names. Each question of the CFQ was scored on a 5-point Likert scale. The 
total score on the CFQ ranges from 0-100, a higher score indicates more self-reported cognitive 
dysfunctioning. Thus, our self-reported HRQoL survey consisted of a total of 69 questions which 
took an estimated 45-60 minutes to answer.  
To guarantee the patient’s privacy, the survey was sent out anonymously and numbered. This 
allowed the primary and supervising investigator to match the returned survey with the patient’s 
registry number in a separate confidential database. 
 
Statistical analyses  
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The differences between those who suffered from delirium  and non-delirium ICU survivors were 
tested non-parametrically using the Mann-Whitney U test. Dichotomous variables were tested 
with the Chi-square test. Since the results of our HRQoL were non-normally distributed, log 
transformation of all HRQoL data was carried out successfully, and the duration of delirium was 
divided into quartiles resulting in normally distributed outcome measurements. The correlation 
between duration of delirium divided into quartiles and the log transformed HRQoL was tested 
using Pearson’s correlation coefficient. Significant differences in demographic variables 
between non-delirium and delirium patients and differences between the delirium subtypes were 
considered as covariates and a multivariate analysis of covariance (MANCOVA) was performed. 
Since there was no difference in age between delirium and non-delirium responders in our 
population, adjusting for age was not necessary. In view of the explorative nature of this study, 
and to increase its sensitivity, no correction for multiple testing was performed.  
Statistical significance was defined as a P-value < 0.05. All data were analyzed using SPSS 
version 16.01 (SPSS, Chicago, IL). 
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Results 
At the median of 18 months prior to this HRQoL survey, in total of 1613 consecutive 
patients who fulfilled the inclusion criteria were admitted (figure 1). In this group 1202 patients 
had no delirium and 411 were delirious during their ICU stay. Overall 183 patients died, of whom 
58 (5%) had not been delirious and 80 (19%) had. The hypoactive delirium subgroup had a 
similar number of survivors as compared to the mixed subgroup, while survival was significantly 
higher (p=0.02) in the hyperactive subgroup (figure 1), median 18 months after ICU discharge. 
In total 55 patients were admitted to the ICU more than once and 14 patients were lost to follow-
up.  
In total, there were 1292 ICU survivors (figure 1) of whom 272 patients (21%) suffered 
from delirium during their ICU stay and 1020 patients did not. In the delirious group 7 patients 
(3%) with a hyperactive subtype of delirium had one positive CAM-ICU screening and 264 
patients had at least two positive CAM-ICU’s during their ICU stay. Median 18 months [IQR 15-
21] after ICU discharge a total of 915 out of the 1292 eligible patients (71%) returned the 
questionnaire. Of these responders 171 out of 272 (63%) patients suffered from delirium during 
their ICU stay and 744 out of 1020 (73%) did not. 788 survivors completed all questionnaires, 
91% completed the SF-36, 98% completed the CIS-fatigue and 97% answered all the questions 
of the CFQ. The demographic data and illness-related characteristics of the responders and 
non-responders are illustrated in table 1. Responders with delirium during their ICU stay were 
significantly more likely to be admitted for urgent reasons and for sepsis, were more likely to be 
female than male, had a higher APACHE II score and their ICU and hospital length of stay was 
significantly longer compared to patients that did not develop delirium during their ICU stay 
(table 2). 
 
Differences between delirium and non-delirium patients on HRQoL 
Short Form-36 
Eighteen months [median 18, IQR 15-21] after ICU discharge patients with delirium during their 
ICU stay rated their quality of life lower on all dimensions of the SF-36 and the physical and 
mental component scores compared to patients who did not have delirium (table 3). However, 
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when adjusted for the covariates APACHE-II score, sepsis, ICU length of stay, gender and 
urgent admission, no statistically significant differences between groups remained. The results 
of our ICU survivors were worse on several domains of the SF-36 compared with an age-
adjusted general Dutch population (table 3) and are in line with those of others (10).  
Checklist Individual Strength-fatigue 
Patients who suffered from delirium experienced more problems with physical exertions 
expressed in a higher total CIS-score compared to the non-delirium patients (table 3). Again, 
after adjusting for covariates, no significant differences in the CIS scores between the two 
groups remained. 
Cognitive Failure Questionnaire 
The delirium survivors reported more pronounced cognitive failure on all measured cognitive 
dimensions compared to patients who did not suffer from delirium. Even after adjusting for 
covariates this difference between the groups persisted. Adjusted for covariates, patients who 
had previously had delirium tended to experience more problems with their memory (P=0.08). 
Overall, their total self-reported cognitive function was significantly impaired. In addition, 
patients with delirium reported significantly more long-term problems with memory and 
concentration after ICU discharge than before when compared with non-delirium patients (table 
3).  
 
Duration of delirium and HRQoL 
The median duration of delirium was two days [IQR 1-7, range 1-69 days]. The delirium duration 
was significantly correlated with the dimensions ‘memory’ (r 0.21; P=0.01) and ‘names’ (r 0.18; 
P=0.04) of the CFQ. This indicates that a longer duration of delirium is related to more 
pronounced problems in memory and remembering names. No other statistically significant 
correlations between duration of delirium and the dimensions of the SF-36 and CIS-fatigue were 
found. 
 
Differences in HRQoL between subtypes of delirium 
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There were no differences between the subgroups of delirium concerning age, APACHE-II 
score, gender and sepsis. However, there were significant differences between the delirium 
subtypes on admission type admission to the ICU for urgent reasons, ICU- and in-hospital 
length of stay (table 4). These variables were considered as covariates. In the unadjusted 
database, survivors of a hypoactive delirium subtype evaluated their HRQoL on several 
dimensions higher compared with hyperactive and mixed delirium survivors. After adjusting for 
the covariates patients who had a hypoactive delirium evaluated their mental health significantly 
better than those who suffered from a mixed or hyperactive  delirium subtype (P=0.01 and 
P=0.04, respectively). 
We found no other significant differences in the SF-36, CIS-fatigue and CFQ tests between the 
subtypes of delirium. Taken together, the three subgroups of delirium suffered more extensive 
cognitive impairment compared to the patients without delirium during their ICU stay.  
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Discussion and conclusion 
We demonstrated that median 18 months after ICU discharge there was no difference 
between patients with delirium and non-delirium patients on all domains of the SF-36 and the 
CIS-fatigue, adjusted for relevant covariates. However, patients who suffered from delirium 
during their ICU stay experienced significantly more cognitive problems than those who did not, 
even after adjusting for covariates. Moreover, delirium duration was significantly correlated to 
problems with memory and names. Interestingly, after adjusting for relevant covariates survivors 
with a hyperactive or mixed subtype of delirium qualified their mental health on the SF-36 as 
significantly worse than the hypoactive delirium patients.  
Delirium is recognized as a frequent disorder with serious short-term health related 
problems and is associated with longer hospital length of stay and increased mortality rates 
(5;28-31). Furthermore, in long-term studies it is recognized that hospitalized, non-ICU, patients 
with delirium suffer from persistent cognitive impairment (32;33). Also, ICU patients suffer from 
persistent cognitive impairment during long-term follow-up (7;34;35), but in these studies no 
distinction between delirious and non-delirious patients was made. A long-term ICU study that 
distinguished between delirious and non-delirious patients showed that, in addition to role 
functioning, there was no statistically significant difference between either group (13) while in 
another long-term study it was observed that duration of delirium was independently associated 
with more pronounced cognitive impairment (6). Definite conclusions cannot be drawn from 
these relatively small studies, because they used a more restricted HRQoL survey (13), their 
maximum follow-up duration was 12 months (6;13), they mainly focused upon cognitive 
impairment (6) and made no adjustments for relevant covariates (13). This last point is of 
particular concern as more severely ill patients have a higher incidence of delirium and long-
term impairments which may not be related to each other (28).   
The strength of the present study is that we used a set of validated questionnaires, such 
as the SF-36, which is the preferred choice for the post ICU setting (21). In addition, because of 
the large sample size we were able to correct for covariates and the longer follow-up 
emphasizes the clinical relevance of the observations. 
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Overall and consistently, each group of delirium subtype evaluated their cognitive functioning 
lower than the patients who did not suffer from delirium during their ICU stay. In our study we 
found that patients who suffered from a hypoactive delirium evaluated their HRQoL on several 
domains of the SF-36 as less affected than the hyperactive or mixed subtype delirium patients. 
After adjusting for relevant covariates the domain mental health remained significantly better in 
hypoactive delirium survivors. The hypoactive subtype is associated with a higher mortality rate 
(36;37), a finding that we confirmed in our study and this may have biased the results to some 
extent.  
Our findings of prolonged cognitive impairment in ICU survivors who suffered from delirium 
corroborate the results of a recent meta-analysis that showed that hospitalized (non-ICU) 
patients with delirium have a significantly increased risk of developing dementia (38). Our 
results that duration of delirium correlates with prolonged cognitive problems further extends the 
reported effects in 77 patients 12 months after their ICU stay (6) and illustrates its clinical 
importance. This may indicate that interventions aimed at reducing delirium incidence and/or 
shortening its duration may produce long-term beneficial effects. This has not been studied yet. 
We wish to acknowledge several study limitations. Firstly, it is intrinsic to long-term research in 
this patient group that the most severely ill may not be alive 18 months after their ICU 
discharge. As the occurrence and duration of delirium is related to increased mortality 
(28;30;39) and the cognitive impairments recover in time (6) this may result in an 
underestimation of  the effects of delirium on cognitive impairment in a long-term study such as 
ours. This implies that the correlation between duration of delirium and HRQoL and cognitive 
impairment could be underestimated in our population. Secondly, we diagnosed delirium on 
minimal one positive CAM-ICU screening during patients ICU stay. One could argue that it is 
better to use at least two consecutive positive CAM-ICU screenings to diagnose delirium. 
However, in all guidelines and delirium protocols we are aware of, patients are treated when 
they meet the criteria of delirium. This is the case following one positive CAM-ICU screening. 
According to our intensive care delirium protocol patients are treated with haloperidol when a 
patient has at least one positive CAM-ICU screening. This early treatment with haloperidol may 
result in negative following CAM-ICU’s. Therefore to include patients with two or more positive 
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CAM-ICU scores may underestimate the presence of delirium in successfully treated patients 
(with haloperidol). To not recognize these patients as delirium patients is in our opinion not 
correct and not in line with daily practice. In addition, in total only 7 out of the 171 responding 
patients with a delirium had only one positive CAM-ICU screening and they were all treated with 
haloperidol following the first positive CAM-ICU. These were all patients with a hyperactive 
delirium subtype. The results of our study would not be influenced if these 7 patients would not 
be included. Thirdly, we adjusted for significant differences in demographic variables between 
non-delirium and delirium patients. As delirium is an independent predictor of longer ICU length 
of stay (28), presumably independent of severity of illness, then adjustment for ICU length of 
stay in the analyses relating delirium to long-term outcomes may underestimate the long-term 
effects of delirium. Furthermore, we measured patients’ long-term evaluation on HRQoL after 
ICU discharge once only. This can be considered as a limitation as we do not know how 
patients’ QoL developed during these 18 months. It appears plausible that the results would 
have been different when we would have also measured them in an earlier stage after 
discharge. Khouli et al. (40) showed that a higher proportion of older patients died within 6 
months after ICU discharge and the HRQoL worsened after 6 months in the oldest group but 
improved in the younger group. However, taking into account the fact that cognitive impairment 
improved in delirium patients between 3 and 12 months after ICU discharge (6) differences 
between the delirium and non-delirium ICU survivors in our group was probably more 
pronounced earlier in the course of recovery. As the aim of our study was to examine the long-
term effects of delirium, we decided not to conduct repeated measures of the HRQoL status in a 
smaller group of patients, instead we chose to measure one point in time, after 18 months, in a 
large group of patients. This allowed adjustment for relevant covariates.  
In conclusion, in this large and long-term follow-up study we demonstrated that ICU 
survivors with delirium during their ICU stay had a similar adjusted health related quality of life 
evaluation, but experienced significantly more cognitive problems in comparison to those who 
did not suffer from delirium. Moreover, the duration of delirium is related to long-term cognitive 
problems.  
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Figure 1. Flowchart of included patients for the Health Related Quality of Life survey 
 
  
14 
 
 
Table 1. Demographic characteristics of responders and non-responders 
 Responders 
(N=915) 
Non-responders 
(N=377) P-value 
Age 65  [57-72] 60  [47-71] <0.0001 
Delirium (N=272) 
- Hypo active (N=94) 
- Hyperactive (N=32) 
- Mixed (N=146) 
171 
63 
19 
89 
(19%) 
(7%) 
(2%) 
(10%) 
101 
31 
13 
57 
(27%) 
(8%) 
(3%) 
(15%) 
0.001 
Gender (M) 609  (67%) 231  (61%) 0.005 
Sepsis (N) 28  (3%) 11  (3%) 0.53 
Urgent admission (N) 389  (43%) 204  (54%) <0.0001 
APACHE-II score  14  [11-17] 13  [10-17] 0.06 
LOS-ICU (days) 1  [1-2] 1  [1-3] 0.03 
LOS-Hospital (days) 7  [5-14] 9  [6-18] 0.001 
Admission type 
- Surgical 
- Medical 
- Trauma 
- Neurology/Neurosurgical 
 
666 
131 
41 
77 
 
(73%) 
(14%) 
(5%) 
(8%) 
 
225  
74  
32  
46  
 
(59%) 
(20%) 
(9%) 
(12%) 
<0.05 
 
Data are expressed as median with IQR unless other reported  
 
 
 
 
 
Table 2. Demographic characteristics of responders  
  Non-delirium       
Patients   
(N=744) 
   Delirium 
   Patients 
   (N=171) 
P-value 
Age 65  [57-72] 65  [58-75] 0.13 
Gender (M) 508  (68%) 101  (60%) 0.01 
APACHE-II score 13  [10-16] 17  [14-20] <0.0001 
Urgent admission (N) 261  (35%) 128  (75%) <0.0001 
LOS-ICU (days) 1  [1-1] 5  [2-11] <0.0001 
LOS-Hospital (days) 7  [5-11] 16  [9-37] <0.0001 
Sepsis (N) 12  (2%) 16  (9%) <0.0001 
Admission type 
- Surgical 
- Medical 
- Trauma 
- Neurology/Neurosurgical 
 
589  
77  
24  
54  
 
(79%) 
(10%) 
(3%) 
(7%) 
 
77  
54  
17  
23  
 
(45%) 
(32%) 
(10%) 
(14%) 
<0.01 
 
 
 
 
Data are expressed as median with IQR unless other reported  
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Table 3. Results of Short Form-36, Checklist Individual Strength-fatigue and the Cognitive Failure Questionnaire 
 measurements 18 months after ICU discharge adjusted for covariates  
 Non-delirium Patients 
(N=744) 
     Delirium Patients 
(N=171) P-value† 
General population 
subgroup age  
55-64y (22) 
SF-36        
Physical Functioning 75 [50-90] 55 [25-80] 0.18 72±26 
67±41 
71±25 
62±20 
82±23 
68±20 
81±35 
77±18 
50±9 
52±10 
Role-Physical 50 [0-100] 25 [0-75] 0.20 
Bodily Pain 78 [57-100] 78 [55-100] 0.26 
General Health 60 [40-75] 55 [35-70] 0.90 
Social Functioning  88 [63-100] 75 [50-88] 0.65 
Vitality 60 [45-75] 55 [40-75] 0.94 
Role-Emotional 100 [33-100] 100 [22-100] 0.64 
Mental Health 80 [64-92] 72 [60-88] 0.26 
Physical Component Score 44 [35-52] 38 31-48] 0.66 
Mental Component Score 53 [43-58] 50 [38-57] 0.61 
CIS 
CIS-total  
 
28 
 
[17-39] 
 
32 
 
[22-44] 
 
0.13 
 
CFQ       
Memory 7.0 [4-10] 8.0 [5-12] 0.08 
Distractibility 11.0 [6-15] 11.0 [7-16] 0.19 
Social blunders 6.0 [4-9] 8.0 [4-10] 0.04* 
Names  3.0 [2-4] 3.0 [2-4] 0.22  
CFQ-total 26 [17-35] 28 [19-39] 0.03* 
Data are expressed as median with IQR or mean with standard deviation (±) 
† adjusted for gender, urgent admission, APACHE-II score, sepsis and LOS-ICU using log transformed data (not shown) 
* <0.05  
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Table 4. Differences between subtypes of delirium on Health Related Quality of Life scores  
 Hypoactive subtype 
(N=63) 
Hyperactive subtype 
(N=19) 
Mixed subtype 
(N=89) 
Age 68 [59-75] 64 [57-75] 64 [57-75] 
Gender (M) 36 (57%) 10  (53%) 55 (62%) 
APACHE-II score 16 [14-21] 14 [13-18] 17 [15-21] 
Urgent admission (N) 43 (68%) 9 (47%) 76 (85%) b-c 
LOS-ICU (days) 4 [2-7] 3 [1-6] 8 [3-16]b-c 
LOS-Hospital (days) 15 [7-29] 10 [5-20] 24 [12-24]b-c 
Sepsis (N) 3 (5%) 1 (5%) 12 (14%) 
Admission type 
- Surgical 
- Medical 
- Trauma 
- Neurology/Neurosurgical 
 
29 
21 
4 
9 
 
(46%) 
(33%) 
(6%) 
(14%) 
 
14 
3 
2 
0 
 
(74%)a 
(16%)a 
(11%)a 
(0%) a 
 
 34 
30 
11 
14 
 
(38%)b-c 
(34%)c 
(12%) 
(16%)c 
SF-36 †       
Physical Functioning 66 [35-85]  32 [15-71] 50 [30-75] 
Role-Physical 50 [0-100] 38 [0-100] 25 [0-63] 
Bodily Pain 78 [67-100] 57 [32-100] 78 [55-100] 
General Health 56 [38-70] 48 [19-65] 50 [35-65] 
Social Functioning  75 [63-100] 63 [34-90] 69 [50-88] 
Vitality 58 [45-76] 50 [35-60] 55 [40-70] 
Role-Emotional 100 [33-100] 83 [17-100] 100 [0-100] 
Mental Health 80 [65-92]a-b 64 [56-84] 72 [52-84] 
Physical Component Score 37 [22-48] 41 [33-49] 36 [29-45] 
Mental Component Score 48 [33-56] 52 [41-59] 49 [37-57] 
CIS †       
CIS-total 30 [16-44] 33 [26-48] 33 [23-44] 
CFQ †       
Memory 9 [5-12] 8 [5-13] 8 [5-12] 
Distractibility 11 [7-16] 11 [6-16] 11 [7-16] 
Social blunders 8 [4-9] 5 [2-11] 8 [5-11] 
Names  3 [2-4] 4 [3-5] 3 [2-4] 
CFQ-total 29 [20-37] 25 [17-39] 29 [19-42] 
† adjusted for urgent, LOS-ICU and in-hospital, admission type using log transformed data (data not shown) 
a significant difference between hypoactive and hyperactive subtype 
b significant difference between hypoactive and mixed type subtype 
c significant difference between hyperactive and mixed type subtype 
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